Learn more about PBS medicines and 60-day prescriptions
PBS co-payment freeze
Find out more about the PBS co-payment freeze and how it works.
Eligibility
Find out if you’re eligible for a 60-day prescription.
Prescribers
Prescribers can use their clinical judgement to decide whether patients receiving PBS medicines are eligible for 60-day prescriptions.
Resources
Find fact sheets, posters and videos about PBS co-payment freeze and 60-day prescriptions.
Stage three – available from 1 September 2024
From 1 September 2024, more 60-day prescriptions will be available for people who live with stable, ongoing health conditions. Stage 3 includes medicines for the treatment of:
- acne
- anxiety disorders
- asthma
- chronic obstructive pulmonary disease (COPD)
- constipation
- depression
- dry eyes
- gastro-oesophageal reflux disease (GORD)
- glaucoma
- Parkinson disease
This is the final stage of implementation for medicines recommended by the Pharmaceutical Benefits Advisory Committee (PBAC) in December 2022 as suitable for a 60-day supply.
More medicines can continue to become available for 60-day prescriptions after they have been deemed suitable and recommended by the PBAC, as part of routine monthly changes to the PBS.
See the full list of medicines available for 60-day prescribing
